Table 2. Analyses of the effects of temperature and dietary P:C ratio for host survival using GLM and development time and pupal weight using ANCOVA.
| effect | Survival | 
Development time | 
Pupal weight | 
|||||
|---|---|---|---|---|---|---|---|---|
| X2 | P | DF | F | P | DF | F | P | |
| Control—unchallenged | ||||||||
| initial weight | 1.73 | 0.19 | 1, 262 | 32.23 | <0.0001 | 1, 262 | 59.51 | <0.0001 | 
| sex | 0.54 | 0.46 | 1, 262 | 35.60 | <0.0001 | 1, 262 | 7.87 | 0.005 | 
| temperature | 4.95 | 0.08 | 2, 262 | 803.44 | <0.0001 | 2, 262 | 24.81 | <0.0001 | 
| diet | 2.43 | 0.12 | 1, 262 | 100.73 | <0.0001 | 1, 262 | 14.03 | 0.0002 | 
| diet2 | 11.88 | 0.0006 | 1, 262 | 152.18 | <0.0001 | 1, 262 | 38.46 | <0.0001 | 
| temperature × diet | 1.75 | 0.42 | 2, 262 | 5.68 | 0.004 | 2, 262 | 3.27 | 0.04 | 
| temperature × diet2 | 2.81 | 0.25 | 2, 262 | 3.22 | 0.04 | 2, 262 | 3.58 | 0.03 | 
| TnSNPV—challenged | ||||||||
| initial weight | 0.59 | 0.44 | 1, 180 | 10.60 | 0.001 | 1, 176 | 11.96 | 0.0007 | 
| sex | 1.46 | 0.23 | 1, 180 | 15.14 | 0.0001 | 1, 176 | 12.80 | 0.0004 | 
| temperature | 0.77 | 0.68 | 2, 180 | 716.95 | <0.0001 | 2, 176 | 9.82 | <0.0001 | 
| diet | 12.18 | 0.0005 | 1, 180 | 9.80 | 0.002 | 1, 176 | 18.41 | <0.0001 | 
| diet2 | 1.67 | 0.20 | 1, 180 | 33.11 | <0.0001 | 1, 176 | 2.21 | 0.14 | 
| temperature × diet | 1.51 | 0.47 | 2, 178 | 0.53 | 0.59 | 2, 176 | 0.76 | 0.47 | 
| temperature × diet2 | 3.54 | 0.17 | 2, 176 | 0.65 | 0.52 | 2, 176 | 3.68 | 0.03 | 
| AcMNPV—challenged | ||||||||
| initial weight | 3.87 | 0.05 | 1, 166 | 9.02 | 0.003 | 1, 162 | 4.14 | 0.04 | 
| sex | 2.99 | 0.08 | 1, 166 | 14.45 | 0.0002 | 1, 162 | 6.33 | 0.01 | 
| temperature | 1.00 | 0.61 | 2, 166 | 1256.41 | <0.0001 | 2, 162 | 23.33 | <0.0001 | 
| diet | 4.40 | 0.04 | 1, 166 | 33.42 | <0.0001 | 1, 162 | 18.80 | <0.0001 | 
| diet2 | 0.02 | 0.89 | 1, 166 | 77.58 | <0.0001 | 1, 162 | 21.60 | <0.0001 | 
| temperature × diet | 2.23 | 0.33 | 2, 164 | 0.99 | 0.37 | 2, 162 | 0.13 | 0.88 | 
| temperature × diet2 | 0.11 | 0.95 | 2, 162 | 0.12 | 0.89 | 2, 162 | 11.39 | <0.0001 | 
Analyses were conducted separately for each virus treatment group. Significant results are in bold font.